Using 18F-fluorodeoxyglucose positron emission tomography to monitor clinical outcomes in patients treated with neoadjuvant chemo-radiotherapy for locally advanced pancreatic cancer. - Wikidata - wikimedia - TriplyDB

Using 18F-fluorodeoxyglucose positron emission tomography to monitor clinical outcomes in patients treated with neoadjuvant chemo-radiotherapy for locally advanced pancreatic cancer.

Using 18F-fluorodeoxyglucose positron emission tomography to monitor clinical outcomes in patients treated with neoadjuvant chemo-radiotherapy for locally advanced pancreatic cancer.

http://www.wikidata.org/entity/Q42030403

about

Utility of PET/CT in diagnosis, staging, assessment of resectability and metabolic response of pancreatic cancer Novel Diagnostic and Predictive Biomarkers in Pancreatic Adenocarcinoma.Neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of prospective studies.Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy.Role of PET quantitation in the monitoring of cancer response to treatment: Review of approaches and human clinical trials.Resection of borderline resectable pancreatic cancer after neoadjuvant chemoradiation does not depend on improved radiographic appearance of tumor-vessel relationships Baseline metabolic tumor volume and total lesion glycolysis are associated with survival outcomes in patients with locally advanced pancreatic cancer receiving stereotactic body radiation therapy.Design considerations for using PET as a response measure in single site and multicenter clinical trials.Multidisciplinary neoadjuvant management for potentially curable pancreatic cancer.Clinically determined type of 18F-fluoro-2-deoxyglucose uptake as an alternative prognostic marker in resectable pancreatic cancer.Prognostic value of 18F-fluorodeoxyglucose positron emission tomography in patients with resectable pancreatic cancer.Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness.Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer.Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies.A molecular imaging primer: modalities, imaging agents, and applications.Neoadjuvant Therapy of Pancreatic Cancer: Definitions and Benefits.The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma.The role of 18F-fluorodeoxyglucose positron emission tomography in the management of patients with pancreatic adenocarcinoma.Challenges in diagnosis of pancreatic cancer.

P2860

Q26827392-3EC9AEBD-A6BE-4713-A6C0-879E46764606 Q30235129-841624BF-E93F-4436-B9E7-573EA66AF756 Q33775311-3AD39FD2-1B1A-491B-A0A3-FB5820F0430E Q34072096-347E3E84-512E-4DAF-821D-8E7143504F6B Q34175770-F0C184A7-71EC-4DAF-B5D9-BCA718266714 Q35155573-98C4341A-6E94-47AE-B50D-460943CBD7AC Q35213015-7D96DF8E-9D43-4CF7-9903-16EE8B9946EC Q35653277-715AF58C-4A6D-47F8-BCDD-FC1F4A11EB41 Q36023889-0520D49E-DD00-4477-AA76-78E9B71CE6B8 Q36290046-EC94F77C-4D90-4BDF-9367-3C44E1FF736A Q37259570-5B4786A9-CF14-43B0-84DE-93463F041389 Q37395832-C145A08D-A697-4A35-A146-0643CC9A826B Q37738012-57F7F638-1FE5-402A-921B-CE75719F62AF Q37968594-2126D4EE-608D-4C06-A037-F9C581FBFE6B Q38005672-D0573201-A3E5-4AD0-A6DE-19511E42C7F4 Q41573034-384CDB39-2019-4EF5-BAE0-F319CB9E9527 Q46876969-034AD52A-27E9-4DF2-837B-302E7AEFBFF2 Q49391836-C8314132-6BCD-4B71-B65F-18C5443EECA4 Q55353877-EDFBCE4E-0CAD-4CE1-AE0E-A2F3FECC5CBD

P2860

Using 18F-fluorodeoxyglucose positron emission tomography to monitor clinical outcomes in patients treated with neoadjuvant chemo-radiotherapy for locally advanced pancreatic cancer.

http://www.wikidata.org/entity/Q42030403

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Using 18F-fluorodeoxyglucose p ...... ly advanced pancreatic cancer.

@en

Using 18F-fluorodeoxyglucose p ...... ly advanced pancreatic cancer.

@nl

type

label

Using 18F-fluorodeoxyglucose p ...... ly advanced pancreatic cancer.

@en

Using 18F-fluorodeoxyglucose p ...... ly advanced pancreatic cancer.

@nl

prefLabel

Using 18F-fluorodeoxyglucose p ...... ly advanced pancreatic cancer.

@en

Using 18F-fluorodeoxyglucose p ...... ly advanced pancreatic cancer.

@nl

P1433

Q42030403-B63FA235-0073-484B-B051-21B0191D2E6C

P1476

Q42030403-09D1CF78-C3FC-456B-B790-7A197C6EE56B

P2093

Q42030403-204C1FFF-8D4C-4A0E-B8A9-CE3EF9E56E85

Q42030403-BBBB82C5-B5FE-4DEA-BA12-3694B116AAC6

Q42030403-E348EE8B-54BE-423D-A726-7A4F4DFBF313

Q42030403-E5CFAD46-EDF0-4FD2-8D50-A0A6EED1EF97

Q42030403-F3CF465B-917A-4CFC-9895-1848A5606BB7

Q42030403-FF02E20A-D7F1-4E09-9844-54BEF80CC053

P2860

Q42030403-104C331C-087D-46C8-9C15-2EE6AE2A3D23

Q42030403-1844823A-4D7F-4B90-9187-273EBCA77305

Q42030403-2FA3D7A1-388E-4113-B2E9-409A7B783E4B

Q42030403-37C66BF5-EB73-419A-A73E-2C714D33488A

Q42030403-56165C49-4C37-4352-9A8F-735E10EA5E94

Q42030403-64840C68-987D-4820-8928-6A7A35DFDA08

Q42030403-65E6A9EC-F96E-4DB3-A59B-945AD428505A

Q42030403-6D88CE35-B088-41DB-887E-7A5CCB4817CD

Q42030403-70790A57-156C-415A-AF36-FCED4E1399DC

Q42030403-7F7FDE80-2D09-4C1A-805B-CD3AAC16B8F4

P304

Q42030403-708B48D6-1046-4EFA-98E3-5440783D3BB2

P31

Q42030403-5B476015-FED7-4CE8-AB35-255E7BF59C37

P356

Q42030403-E2D3C38A-CC57-4F2C-BD9F-259F0818FAEE

P433

Q42030403-220336E5-D5F2-4E7E-B6BF-02E3D698083A

P478

Q42030403-22567CC0-0CC2-4A89-85EB-AF11A69D9445

P577

Q42030403-4F67CF06-9432-4382-8FC7-6A82588BE9CA

P698

Q42030403-05FD05EF-4D42-44EF-BF1E-E49A6C3E58D2

P921

Q42030403-67B517AE-A3A3-4082-8392-77D4B270C910

P932

Q42030403-54195210-768F-4A49-975D-C8D7B49FB087

P356

COC.0B013E3181A76A0B

P1433

American Journal of Clinical Oncology

P1476

Using 18F-fluorodeoxyglucose p ...... ly advanced pancreatic cancer.

@en

P2093

Anthony F Shields

http://www.w3.org/2001/XMLSchema#string

Jawana M Lawhorn-Crews

http://www.w3.org/2001/XMLSchema#string

Lance K Heilbrun

http://www.w3.org/2001/XMLSchema#string

Mark M Zalupski

http://www.w3.org/2001/XMLSchema#string

Minsig Choi

http://www.w3.org/2001/XMLSchema#string

Raghu Venkatramanamoorthy

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2008

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

Value of 18-fluorodeoxyglucose positron emission tomography in the management of patients with cystic tumors of the pancreas

18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer.

Positron emission tomography (PET) and other nuclear medicine modalities in staging gastrointestinal cancer.

Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A Phase II Study.

Measuring response to chemotherapy in locally advanced breast cancer: methodological considerations.

Monitoring response to treatment in patients utilizing PET.

FDG-PET in the prediction of survival of patients with cancer of the pancreas: a pilot study.

[Fluorodeoxyglucose positron emission tomography (FDG-PET) in the differential diagnosis of pancreatic lesions]

P304

257-261

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/COC.0B013E3181A76A0B

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19806035

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

3848057

http://www.w3.org/2001/XMLSchema#string